Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

Kodak buying medical imaging operation

Article Abstract:

The Imation Corp.'s medical imaging business will be acquired by Eastman Kodak Co. for $520 million in cash. The deal is a dramatic shift for Eastman Kodak's, which had a recent record of employee layoffs and cost-cutting efforts. Kodak, which has about 30% of the global medical imaging market with $1.6 billion in revenues, will benefit from Imation's leadership in the rapidly-growing market for dry laser imaging. The deal also calls for Kodak to purchase X-ray film from Imation's Italian-based plant for two years.

Author: Deutsch, Claudia H.
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: Business, general
ISSN: 0362-4331
Year: 1998
Photographic and Photocopying Equipment Manufacturing, Electromedical and Electrotherapeutic Apparatus Manufacturing, Licensing/Sales Agreements, Photographic Equip & Supplies, Medical Imaging & Scanning, Photographic industry, Eastman Kodak Co., Imation Corp., Medical imaging equipment

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Nova of Canada to purchase Huntsman Styrene business

Article Abstract:

The styrene business of Hunstman Corporation will be acquired by Nova Corporation for $860 million US in preferential stock and cash, giving Nova about 13% of the world's styrene capacity. The deal will propel Nova, which will become the world's leading styrene producer, past its rivals BASF of Germany and Dow Chemical. The deal will provide Hunstman, which is the largest privately held chemical company in the US, with $625 million in cash and $235 million of non-voting preferred shares of Nova stock.

Comment:

Will acquire the styrene business of Hunstman Corporation for $860 mil US in preferential stock and cash

Author: Deutsch, Claudia H.
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: Business, general
ISSN: 0362-4331
Year: 1998
Canada, Company Planning/Goals, Natural Gas Distribution, Gas Transmissn & Distributn, Styrene Resins, Gas industry, Nova Corporation of Alberta, Hunstman Corporation

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Ciba is set for a merger with Clariant

Article Abstract:

Ciba Specialty Chemicals and Clariant have agreed to a merger worth about $7 billion. The two chemical giants will take the name of Clariant and the butterfly logo of Ciba. Combined sales are estimated to be $13 billion. Ciba's chairman, Rolf A. Meyer, will be the new company's CEO; Clariant's chairman, Rolf W. Schweizer, will be chairman.

Author: Deutsch, Claudia H.
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: Business, general
ISSN: 0362-4331
Year: 1998
Plastic Materials, Plastics materials and resins, Cyclic crudes and intermediates, Synthetic Organic Dye and Pigment Manufacturing, Organic Dyes & Pigments, Mergers, acquisitions and divestments, Chemicals, Plastics, Abstract, Specialty chemicals industry, Ciba Specialty Chemicals Inc., Clariant Corp., Organic dyes

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Article
Similar abstracts:
  • Abstracts: Hunting a bargain at a Web auction. A family links up, but united we fall
  • Abstracts: British Petroleum is buyng Amoco in $48.2 billion deal. MCI to sell Internet assets; merger wins an approval
  • Abstracts: Alcohol firms boost online ads to youth. Philip Morris taps old formula to help boost Miller Lite brand
  • Abstracts: Marsh & McLennan will buy Sedgwick. TRW to buy Lucas Varity for $7 billion
  • Abstracts: Pepsico to pay $3.3 billion for Tropicana. Pepsico studies possible conversion of bottling operations
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2023 Advameg, Inc.